secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orchestra BioMed Holdings, Inc. (OBIO)
CIK:        0001814114
Form:       8-K
Filed at:   2022-02-10T23:59:59+00:00
Accession:  0001213900-22-006431
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 4.02
LLM model:  deepseek-v4-flash:cloud@v2

Health Sciences Acquisitions 2 restates financial statements due to equity classification error
--------------------------------------------------------------------------------

- Audit committee concludes all ordinary shares should be classified as temporary equity, not permanent.
- Restatement covers six prior filings from August 2020 through September 2021, including IPO balance sheet.
- No impact on cash position or trust account; earnings per share presentation also revised.
- Material weakness in internal control over financial reporting identified; disclosure controls ineffective.
- Company plans to file amended 10-K, 10-Q, and 8-K to correct the affected periods.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1814114/000121390022006431/0001213900-22-006431-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1814114/000121390022006431/ea155233-8k_healthsci2.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-006431

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer